Daniel Corless Email & Phone Number

Minneapolis, MN, US

Beverly Hills, CA, US

Partnered with Platinum Equity and Peli BioThermal leadership to drive company-wide transformation and value-creation initiatives. Additionally, led a Platinum-level commercial due diligence.

Maple Grove, Minnesota, US

Hired to lead refinement and execution of transformation and value-creation initiatives to accelerate growth across the company.

Minneapolis, MN, US

• Promoted to lead value creation, strategy & M&A for the 1,000+ FTE, $130M+/yr revenue Life Sciences division - providing testing, CDMO, GXP, and FDA regulatory services to biopharma clients. Pace is a Leonard Green &.
• Selected by CEO as deal team member in 2021 Pace sale to LGP; led market report & co-led pitch book creation
• Led 5-year and annual strategic growth planning process as well as working with the division President to set revenue and EBITDA targets, driving all build and buy decisions, resulting in 2020-2022 revenue growth of.
• Led divisional M&A actions from strategy, banker relationships, target identification & screening, due diligence; supported term sheet structuring & negotiations, deal closing and post-merger integration, closing 5.
• Drove internal merger of the Scientific Professional Services (SPS) and Pharma Life Science (PLS) divisions to create one diversified biopharma-focused division spanning CDMO, and GXP & FDA consulting services
• Charged by CEO to lead initiatives in the Environmental Division (~$350M/yr revenue, largest environmental testing network in US) to refine 5-year strategy and led action implementation planning with sales and.

Minneapolis, MN, US

• Reporting to the CEO, hired as VP/COO to turn around a 450+ FTE, ~$40M/yr revenue scientific services business during the pandemic, repositioned for growth, and in less than a year, exceeded top and EBITDA growth.
• Repositioned the 5-business line portfolio to focus on the biopharma market by driving sales, EBITDA growth, and operations
• Delivered growth by setting and executing strategic plans, both organic and M&A - including target screening, due diligence; supported term sheet structuring & negotiations
• Leveraged internal resources to drive biopharma market growth by breaking down internal siloes, launching a collaborative initiative with Pace Life Science, aligning cross-division commercial, operational, and.

• Advised private equity portfolio companies on value creation through growth strategy & transformation.
• Led projects identifying growth levers for organic (new markets, pricing) as well as M&A (target search & screen)

New York, NY, US

• Hired to bring extensive M&A due diligence and buy- & sell-side transaction support to advise technology (edtech, SaaS- and cloud-based) C-suite and private equity clients. Additionally, co-led BD and sales efforts.
• Completed multiple buy- and sell-side engagements totaling ~$750M in transaction value
• Utilized quantitative & qualitative surveys, as well as market and consumer data in B2C environments to project future revenue, assess customer interest, evaluate key purchase criteria, and determine NPS
• Contributed to several business development efforts to generate proposals and sell engagements

Boston, MA, US

• Led simultaneous projects providing commercial strategy, value creation, merger & acquisition due diligence, transaction support, and valuation advice to private equity, corporate, investment banking, and sovereign.
• Completed 10+ client projects representing ~$2B in transaction value
• Pre-merger activities: Commercial strategy, therapy & disease area screening, target screening as well as buy- and sell-side commercial due diligence
• Post-merger activities: Private equity portfolio company value creation - revenue growth and EBIDTA driver plans / playbooks
• Disease areas: Oncology, neurology, biosimilars, and rare & orphan disease
• Industries served: small, medium, and large pharmaceutical/biotech; medical device companies as well as contract service organizations (patient services and CDMO/CMO)

Durham, North Carolina, US

• Provided consulting advice to Life Sciences clients, focusing on mergers & acquisitions as well as commercial and portfolio strategy, leveraging IQVIA MIDAS prescription drug sales & volume data and analytical tools.
• Conducted commercial due diligence assignments on targets for C-level clients preparing for acquisitions, representing ~$1.5B in transaction value
• Led launch and lifecycle strategy for client launching first product, included creation of revenue forecast and NPV model
• Co-led business development activities to grow the firm's NYC-area private equity client base

Worldwide, OO

• Provided consulting advice to Life Science clients with a focus on mergers & acquisitions.Participated in aggregate Life Science M&A transactions totaling over $10B in the following areas:
• Pre-merger activities: Commercial strategy, target screening, commercial due diligence, and planning for synergy, integration & Day One preparations
• Post-merger integration (PMI): synergy & value capture

Chicago, US

• Promoted to provide strategic leadership globally for BioProcess Equipment and Validation Services as well as lead Validation Services as P&L owner.
• Served as a strategic leader with responsibility for all BioProcess Services product management, delivering over 10% top-line growth and over $20M of EBITDA in 2013 through a global team of 25 employees
• Led integration of acquired Validation business to ensure the seamless merger of teams and operations.
• Participated in sourcing, term sheet evaluation and negotiations for strategic partnerships
• Led Innovation & Technology team for a $200M/yr business to develop and commercialize Life Science Service tools.

Chicago, US

• General Manager and P&L owner of 2 distinct business lines (aftermarket instruments and validation services), driving global growth. Led a globally dispersed team of 13 employees.
• Acted as commercial leader for various growth & operational efficiency initiatives to grow revenues by 100% and EBITDA to over $13M in 2012.
• Managed team of 13 employees worldwide to ensure seamless collaboration despite the geographic dispersion.
• Led a cross-functional team to re-define the global services strategy for the $1B/yr BioProcess business.

Chicago, US

• Created, launched & managed (P&L owner) a new business line to establish GE as a reseller of life sciences instruments.
• Conducted market research & developed financial projections to write business plan; secured financial & operational resources; and built out all business operations, to generate $3M+ in revenues in first full year.
• Delivered 1st sale within 6 months of launch & achieved positive cash flow in 9 months; initial IRR of 330%.
• Simultaneously co-founded instrument leasing business to generate $2.5M+ in lease revenues in first year.Awards:
• GE Healthcare Excellence Award for commitment to Quality and Compliance, 2011.
• GE Healthcare Innovation Award for developing and launching a new business, 2010.

Boston, MA, US

• Completed four 6-month rotations to gain visibility into and operational experience with several business divisions.
• Worked as part of cross-functional team to execute a major re-branding & business transformation initiative for $4B/yr global medical equipment division.
• Built financial model and led cost-cutting project spearheaded by the Diagnostic Imaging division CMO, resulting in the reduction of initial program costs by 35 percent.
• Conducted comprehensive audit of variable compensation system for $2B/yr medical equipment business; built financial model to test & validate system for variable compensation calculation, reconciliation & payout metrics.
• Co-led the annual business plan & strategic roadmap process for a $145M/yr global P&L within Life Sciences.

Waltham, MA, US

• Analyzed molecular biology customers to help the company understand customer loyalty and retention drivers.
• Conducted segmentation analysis of customers and utilized company’s sales organization to develop and implement marketing strategy.

Waltham, MA, US

• Responsible for growing & maintaining business and sales relationship between Fisher Scientific and a top 10 global pharmaceutical company in Massachusetts including sales/marketing, supply chain/logistics and.
• Led numerous business development initiatives including formation of strategic partnerships with outside vendors to consistently exceed annual business plan for the account (109% in 2005).
• Developed and led cross-functional team to execute vendor managed inventory program for mission critical production plant consumables to reduce client’s costs by 30 percent.

Plantsville, CT, US

• Responsible for sales growth of telecommunications equipment in under-served territories.
• Initiated and developed client relationships to increase account base from 25 to 75 clients.Awards: Agilent Technologies Recognition of Sales Excellence, 2001.

Mba, Finance And Entrepreneurship

B.S., Biology